PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...

Please provide your email address to receive an email when new articles are posted on . “We are excited to be developing a simple test that clinicians can use to estimate the level of vision in ...

Please provide your email address to receive an email when new articles are posted on . Aura Biosciences announced positive visual acuity results from a phase 1b/2 trial of its cancer drug AU-011 in ...

ABU DHABI, UAE — Thrombolysis to treat central retinal artery occlusion, also known as “eye stroke,” appeared to improve visual acuity compared with oral aspirin but this did not reach statical ...

This is a preview. Log in through your library . Abstract This study investigated whether men and women are equally likely to adapt their driving behaviors in response to visual limitations.